Tolterodine is as effective as oxybutynin in improving micturition diary variables but is associated with a significantly lower incidence and intensity of dry mouth.
English language randomized controlled trials with keyword tolterodine.
May increase risk of gastric retention in patients with decreased GI motility or gastrointestinal obstructive disorders. A unique ID assigned by the FDA when a product is submitted for approval by the labeller. Animal studies show risk and human studies not available or neither animal nor human studies done.
Tolterodine is a competitive muscarinic receptor antagonist. Do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can perform such activities safely. A unique ID assigned by the FDA when a product is submitted for approval by the labeller. It is important for you to keep a written list of all of the prescription and nonprescription over-the-counter medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements.
This antagonism results in inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder. This medication may make you sweat less, making you more likely to get heat stroke.
Ask your doctor before use if you are taking the following medications:
Drinking alcohol can increase some of the side effects and can also increase your risk of seizures.
It should be used with caution in those who have underlying liver problems or cardiac disorders.
This helps reduce alertness and promote that first drowsy stage of sleep, helping you to then drift off into a restful, deeper sleep.
Normally when acetylcholine acts on these receptors, it causes the detrusor muscle to contract and the bladder to empty. Patient does not provide medical advice, diagnosis or treatment. There is no information available about the safety of this medicine during pregnancy.